US 11702423
BRM targeting compounds and associated methods of use
granted A61PA61P35/00A61P35/02
Quick answer
US patent 11702423 (BRM targeting compounds and associated methods of use) held by Prelude Therapeutics, Incorporated expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Prelude Therapeutics, Incorporated
- Grant date
- Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P35/00, A61P35/02